Current and emerging antiviral treatments for hepatitis C infection
about
Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.Eradication of hepatitis C infection: the importance of targeting people who inject drugs.Hepatitis C transmission and treatment in contact networks of people who inject drugs.Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot studyTargeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.The changing burden of hepatitis C virus infection in the United States: model-based predictions.Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.Experimental therapies for yellow feverSequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.Albumin-drug conjugates in the treatment of hepatic disorders.Albumin nanostructures as advanced drug delivery systems.Effect of Treatment for CHC on Liver Disease Progression and Hepatocellular Carcinoma Development in African Americans.The changing landscape of hepatitis C treatment-not 'can we cure?' but 'who should we cure first?' Is this an ethical approach?The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs.A comparison of risk factors for hepatitis C among young and older adult prisoners.Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.
P2860
Q30884457-E876BD77-D5A5-4C74-84C5-8AB697D5D399Q34984077-25F07705-39E9-425B-94A2-EACD3BFEEDA3Q35040866-475E89A7-A535-4BB0-BF96-C06DF2785B6FQ35046392-F8F0C5E8-C279-4449-8E6A-09B1C09AC3E8Q35115534-EBFC5E0A-774A-4CE4-9E1B-57FF431CD121Q35168083-CF68290B-2BB7-4DCE-B066-2F9843CF152AQ36200292-7BF0A157-623B-48B5-AAD0-AD718D8A0B85Q36586306-BE79A8DE-BF36-4C1D-B5A0-CBC9E2038167Q37125237-26664B49-FCBA-4192-97B0-B6BFD5D25C71Q37288631-7C01F6DD-67DF-4DEC-AC9B-F4CC9A9DD305Q38207699-867AC1DF-B1BB-4BF0-9F9B-4FE20BA499E6Q38842596-914DCEFA-4B83-44B6-9BC5-C382C322F938Q41084425-7F2CACC7-732C-4947-8839-ADE68F176D99Q41745288-77E2D43E-93EE-44B0-8E76-9A4C399DD4E6Q42197246-C8210700-99B3-4C74-BFEE-BEC866F0A838Q50640446-4254A50A-0C46-4C7B-A6C0-EE5BFE4B03D1Q52597020-7DD619BD-5BEF-49BB-AB78-A53D251AAFD5
P2860
Current and emerging antiviral treatments for hepatitis C infection
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Current and emerging antiviral treatments for hepatitis C infection
@ast
Current and emerging antiviral treatments for hepatitis C infection
@en
type
label
Current and emerging antiviral treatments for hepatitis C infection
@ast
Current and emerging antiviral treatments for hepatitis C infection
@en
prefLabel
Current and emerging antiviral treatments for hepatitis C infection
@ast
Current and emerging antiviral treatments for hepatitis C infection
@en
P2093
P2860
P1476
Current and emerging antiviral treatments for hepatitis C infection
@en
P2093
Alexander J Thompson
Esther Aspinall
Margaret E Hellard
P2860
P304
P356
10.1111/J.1365-2125.2012.04419.X
P407
P577
2013-04-01T00:00:00Z